David Sinclair: Longevity Genius, Salesman, or Both? What Patients Should Know Before Buying the Hype

For nearly two decades, David Sinclair has been the most famous scientist in the business of not dying. Harvard genetics professor. Founding director of the Paul F. Glenn Center for Biology of Aging Research. Author of Lifespan: Why We Age and Why We Don’t Have To, the 2019 bestseller that turned “reverse aging” into dinner-party conversation. One of TIME’s 100 most influential people. Podcast host. Co-founder, by his own description, of several biotech companies. And, if you have ever sat in a regenerative medicine clinic and heard the words “NAD+ drip,” “NMN,” or “epigenetic age,” you have almost certainly heard his name used to sell you something.

That is the reason for this article. Sinclair does not run a clinic. But his ideas, his book and his face have become the marketing department for an entire industry, and a growing number of his fellow aging researchers have gone from admiring him to publicly calling him out. Is David Sinclair legit? The honest answer is: it depends which David Sinclair you mean.

The scientist: three big ideas

Sirtuins and the red-wine molecule. In the early 2000s, Sinclair’s lab reported that resveratrol, a compound found in red wine, switched on sirtuins, a family of proteins linked to lifespan in yeast. The story was irresistible: a glass of Bordeaux, a longer life. Sinclair co-founded Sirtris Pharmaceuticals to turn it into a drug, and in 2008 GlaxoSmithKline bought the company for $720 million.

NAD+ and NMN. Next came NAD+, a molecule every cell needs and that declines as we age. Sinclair became the leading champion of NMN, a precursor the body converts to NAD+, as a way to restore youthful cell function. NMN supplements are now a global business, and his name is on most of the marketing.

The information theory of aging. His most ambitious idea, and the one serious scientists take most seriously: that aging is largely a loss of epigenetic information, the software that tells each cell which genes to read, and that this loss can be partly reversed. In one striking experiment, his lab reported restoring vision in old mice by reprogramming cells in their eyes. Many labs are now chasing the same idea.

So far, so impressive. The trouble starts with the gap between the mouse and the patient, and with how that gap gets described.

The controversies: where the applause stopped

Resveratrol turned out to be a mirage. By 2005, other researchers had shown that the lab test used to conclude resveratrol activated sirtuins was flawed: a fluorescent dye in the assay was reacting with the resveratrol itself. GSK, having paid $720 million, wound down the Sirtris program within five years without a drug to show for it. Resveratrol is still sold as a longevity supplement. There is no human evidence it extends life.

The NMN fight with the FDA. Metro International Biotech, a company Sinclair co-founded and which now lists him as a scientific advisor, is developing a patented form of NMN as a prescription drug. In 2022, after the company filed NMN in a drug application, the FDA ruled that NMN could no longer be sold as a dietary supplement. The supplement industry cried foul, arguing the decision handed a public ingredient to a private company; the FDA reversed itself in September 2025.

Strip away the legal drama and the human evidence for NMN is modest: short trials show it raises NAD+ in the blood and may nudge a few measures in older adults. None has shown longer life or healthier aging.

The dog supplement that cost him his presidency. In February 2024, a press release from Animal Biosciences, a company Sinclair co-founded with his brother, quoted him saying a supplement had reversed aging in dogs. The product’s ingredients were undisclosed; the data were unpublished. The reaction from the field was immediate. Matt Kaeberlein, a University of Washington aging researcher and co-founder of the Dog Aging Project, wrote publicly that the press release was dishonest and the claim a lie.

Members resigned in a wave from the Academy for Health and Lifespan Research, the scientific society Sinclair had co-founded and led. Fellow board members pressed him to step down as president, and he did, while insisting the quote had been inaccurate and his critics were mischaracterizing his work. The Wall Street Journal covered the episode in detail.

The pattern critics see. Each of these episodes has an explanation. Taken together, researchers including Kaeberlein and Charles Brenner argue that Sinclair habitually presents early animal findings as if they were near-term human treatments, and that a company he has an interest in is rarely far from the claim. Sinclair’s general reply is that his lab works ahead of the field and that the criticism reflects that.

Why David Sinclair matters when you are sitting in a clinic

Here is the part that affects your wallet. NAD+ infusions, NMN protocols, resveratrol regimens and “biological age” tests have become standard items on regenerative and longevity clinic menus, usually at several hundred dollars a session, and Sinclair’s name and book are the usual justification. The science he is famous for is real and interesting. The products sold in his shadow mostly are not backed by human evidence, and he is not the one selling them.

So when a provider mentions David Sinclair, treat it as a cue to ask two questions. First: what human study, not mouse study, supports this treatment for someone like me? Second: what will you measure, and when, to know whether it worked? A provider who can answer both is worth listening to. One who answers with a book title is not.

David Sinclair’s ideas deserve to be taken seriously. His name, on its own however, is not evidence.

His book, Lifespan: Why We Age and Why We Don’t Have To, is available on Amazon.

David Sinclair: quick answers for patients

Is David Sinclair legit?

He is a real Harvard scientist whose lab has published influential aging research. The criticism from other researchers is about how early animal findings are presented to the public, and about commercial ties to the products that benefit from those claims.

Is NMN proven to slow aging?

No. Short human trials show NMN can raise NAD+ levels in the blood. None has shown that it extends life or produces healthier aging.

Does resveratrol extend human life?

There is no human evidence that it does.

Should I trust a clinic that cites David Sinclair?

Ask for the human study that supports the specific treatment you are being offered. A famous name is not a substitute for evidence.

Related reading

• Peptides for longevity: what has actually been studied
• Cell rejuvenation: scientists rewind the clock on an 80-year-old’s cells
• 12 questions to ask a regenerative clinic before you pay
• Find longevity and healthy aging providers
• FDA consumer alert on regenerative medicine products

Sources: The Sinclair Lab, Harvard Medical School; Wikipedia, “David A. Sinclair” (with cited references); The Wall Street Journal via Slashdot, “Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism,” May 1, 2024; Matt Kaeberlein on X, March 2024; SupplySide Supplement Journal, “FDA says anti-aging supplement ingredient B-NMN can only be a drug,” November 2022; NMN.com, “FDA Reverses Course and Dubs NMN Lawful in Dietary Supplements,” September 2025; MetroBiotech.com, scientific advisory board; Animal Biosciences press release, February 28, 2024. This article is educational and is not medical advice.